Compression Therapy Market by Technique, Product (Bandages, Wraps, Stockings, Tapes, Ortho Braces, Pump), Application (Varicose Vein, DVT, Lymphedema Ulcer), Distribution Channel(Hospitals, Clinics, Pharmacies, E-Commerce) - Global Forecast to 2027
The compression therapy market size is expected to grow from an estimated USD 3.7 billion in 2022 to USD 4.9 billion by 2027, at a CAGR of 5.5%. Rising global prevalence of diabetes, venus leg ulcer, deep vein thrombosis and rapid growth in the older population with orthopedic disorders are likely to boost the adoption of compression therapy products. Growing cases of sports injuries, favorable clinical evidence for the use of compression therapy products in the management of several diseases and new developments in compression therapy by global giants are further anticipated to support the growth of the market.
“Compression pumps segment is expected to witness the highest growth rate during the forecast period”
On the basis of product, the compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression tapes, compression pumps, compression braces, and other compression garments. Compression pumps segment is anticipated to register the highest CAGR during the forecast period. Factors such as the increasing incidence of cancer, the rising prevalence of chronic venous diseases, and the growing number of hip and knee surgeries are expected to drive the growth of the compression pumps market during the forecast period.
“varicose vein treatment segment to capture the largest market share or compression therapy market in 2021, by application
On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. The varicose vein treatment segment accounted for the largest share the compression therapy market in 2021. The large share of this segment is mainly driven by the increasing prevalence of varicose veins, the high preference for compression therapy as the first line of treatment for varicose veins,
”The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global compression therapy market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa). During the forecast period of Asia Pacific market is estimated to grow at the highest CAGR owing to the increase in patient population with diabetes, large geriatric patient pool, growing prevalence of orthopedic disorders and improved healthcare infrastructure in the region.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the compression therapy market based on product, technique, application, distribution channel, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
“Compression pumps segment is expected to witness the highest growth rate during the forecast period”
On the basis of product, the compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression tapes, compression pumps, compression braces, and other compression garments. Compression pumps segment is anticipated to register the highest CAGR during the forecast period. Factors such as the increasing incidence of cancer, the rising prevalence of chronic venous diseases, and the growing number of hip and knee surgeries are expected to drive the growth of the compression pumps market during the forecast period.
“varicose vein treatment segment to capture the largest market share or compression therapy market in 2021, by application
On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. The varicose vein treatment segment accounted for the largest share the compression therapy market in 2021. The large share of this segment is mainly driven by the increasing prevalence of varicose veins, the high preference for compression therapy as the first line of treatment for varicose veins,
”The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global compression therapy market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa). During the forecast period of Asia Pacific market is estimated to grow at the highest CAGR owing to the increase in patient population with diabetes, large geriatric patient pool, growing prevalence of orthopedic disorders and improved healthcare infrastructure in the region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
- By Designation: C-level–10%, Director-level–14%, and Others–76%
- By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
Research Coverage
This report studies the compression therapy market based on product, technique, application, distribution channel, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the compression therapy market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the compression therapy market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the compression therapy market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 KEY MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Indicative list of secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 RECESSION IMPACT
2.3.1 IMPACT OF RECESSION ON COMPRESSION THERAPY MARKET
2.4 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 7 COMPRESSION THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 8 COMPRESSION THERAPY MARKET SHARE, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 COMPRESSION THERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 10 COMPRESSION THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF COMPRESSION THERAPY MARKET
4 PREMIUM INSIGHTS
4.1 COMPRESSION THERAPY MARKET OVERVIEW
FIGURE 12 GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH
4.2 COMPRESSION THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 13 COMPRESSION PUMPS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 STATIC COMPRESSION THERAPY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)
FIGURE 15 HOSPITALS & CLINICS TO ACCOUNT FOR LARGEST SHARE OF COMPRESSION THERAPY MARKET IN 2027
4.5 COMPRESSION THERAPY MARKET, BY REGION, 2020–2027
FIGURE 16 ASIA PACIFIC TO WITNESS FASTEST GROWTH IN MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Large target patient population
FIGURE 18 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050
5.2.1.2 Growing incidence of sports injuries and accidents
FIGURE 19 EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 2021
5.2.1.3 Increasing number of orthopedic procedures
5.2.1.4 Greater product affordability and market availability
5.2.1.5 Clinical evidence favoring adoption of compression therapy for management of target conditions
5.2.2 RESTRAINTS
5.2.2.1 Lack of universally accepted standards for compression products
5.2.2.2 Low patient compliance with compression garments
FIGURE 20 REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential offered by emerging markets
5.2.3.2 Growing patient awareness regarding benefits of compression therapy
5.2.3.3 Increased sales of off-the-shelf and online products
5.2.4 CHALLENGES
5.2.4.1 Significant adoption of alternative therapies for specific target indications
5.2.4.2 Increasing pricing pressure on market players
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 OVERVIEW
TABLE 2 COMPRESSION THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.2 BARGAINING POWER OF BUYERS
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 THREAT FROM NEW ENTRANTS
5.3.5 THREAT FROM SUBSTITUTES
5.3.6 INTENSITY OF COMPETITIVE RIVALRY
5.4 PRICING TREND ANALYSIS
5.4.1 AVERAGE SELLING PRICE, BY PRODUCT
TABLE 3 AVERAGE PRICE OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)
5.4.2 AVERAGE SELLING PRICE, BY REGION
TABLE 4 REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)
5.5 TECHNOLOGY ANALYSIS
5.5.1 WIRELESS BIOSENSORS
5.5.2 GARMENT MANUFACTURING TECHNOLOGIES
5.6 REGULATORY ANALYSIS
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.6.1.2 Canada
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2 EUROPE
FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6.3.2 China
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
5.7 REIMBURSEMENT SCENARIO
TABLE 10 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2021
5.8 VALUE CHAIN ANALYSIS
FIGURE 23 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.9.3 END USERS
FIGURE 24 SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM ANALYSIS
5.10.1 PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS
5.11 PATENT ANALYSIS
FIGURE 25 PATENT ANALYSIS
5.12 TRADE ANALYSIS
TABLE 11 IMPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)
TABLE 12 EXPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)
5.13 KEY CONFERENCES & EVENTS, 2022–2023
5.13.1 COMPRESSION THERAPY MARKET: LIST OF MAJOR CONFERENCES & EVENTS
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY DISTRIBUTION CHANNEL
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL (%)
5.14.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL
TABLE 14 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL
6 COMPRESSION THERAPY MARKET, BY TECHNIQUE
6.1 INTRODUCTION
TABLE 15 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
6.2 STATIC COMPRESSION THERAPY
6.2.1 PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH
TABLE 16 STATIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 DYNAMIC COMPRESSION THERAPY
6.3.1 RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET
TABLE 17 DYNAMIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
7 COMPRESSION THERAPY MARKET, BY PRODUCT
7.1 INTRODUCTION
TABLE 18 COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
7.2 COMPRESSION BANDAGES
7.2.1 LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH
TABLE 19 COMPRESSION BANDAGES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 20 COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 21 COMPRESSION BANDAGES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 22 COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.3 COMPRESSION WRAPS
7.3.1 RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET
TABLE 23 COMPRESSION WRAPS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 24 COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 25 COMPRESSION WRAPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 26 COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.4 COMPRESSION STOCKINGS
TABLE 27 COMPRESSION STOCKINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 28 COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 29 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 30 COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 31 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.4.1 CLASS I COMPRESSION STOCKINGS
7.4.1.1 Advantages such as comfort and durability to drive demand for class I stockings
TABLE 32 CLASS I COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.4.2 CLASS II COMPRESSION STOCKINGS
7.4.2.1 Increasing number of lymphedema and DVT patients to fuel demand
TABLE 33 CLASS II COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.4.3 CLASS III COMPRESSION STOCKINGS
7.4.3.1 High level of compression provided to boost adoption of class III stockings
TABLE 34 CLASS III COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.5 COMPRESSION TAPES
7.5.1 ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES
TABLE 35 COMPRESSION TAPES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 36 COMPRESSION TAPES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 37 COMPRESSION TAPES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 38 COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.6 COMPRESSION PUMPS
TABLE 39 COMPRESSION PUMPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 41 COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 42 COMPRESSION PUMPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 43 COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.6.1 INTERMITTENT PUMPS
7.6.1.1 Availability of wide range of intermittent pumps with varying designs and complexity to boost demand
TABLE 44 INTERMITTENT COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.6.2 SEQUENTIAL PUMPS
7.6.2.1 Wide usage to prevent development of DVT to boost growth
TABLE 45 SEQUENTIAL COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.7 COMPRESSION BRACES
7.7.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET
TABLE 46 COMPRESSION BRACES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 47 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 48 COMPRESSION BRACES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 49 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.8 OTHER COMPRESSION GARMENTS
TABLE 50 OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 51 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 52 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
8 COMPRESSION THERAPY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 54 COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027(USD MILLION)
8.2 VARICOSE VEIN TREATMENT
8.2.1 GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET
TABLE 55 COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2020–2027 (USD MILLION)
8.3 DEEP VEIN THROMBOSIS TREATMENT
8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH
TABLE 56 COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2020–2027 (USD MILLION)
8.4 LYMPHEDEMA TREATMENT
8.4.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH
TABLE 57 COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2020–2027 (USD MILLION)
8.5 LEG ULCER TREATMENT
8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET
TABLE 58 COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2020–2027 (USD MILLION)
8.6 OTHER APPLICATIONS
TABLE 59 COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL
9.1 INTRODUCTION
TABLE 60 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.2 PHARMACIES & RETAILERS
9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH
TABLE 61 COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2020–2027 (USD MILLION)
9.3 E-COMMERCE PLATFORMS
9.3.1 E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD
TABLE 62 COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2020–2027 (USD MILLION)
9.4 HOSPITALS & CLINICS
9.4.1 HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH
TABLE 63 COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)
9.5 HOME CARE SETTINGS
9.5.1 GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET
TABLE 64 COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
10 COMPRESSION THERAPY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 65 COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT
TABLE 66 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 Rising number of sports injuries to drive market growth
TABLE 71 US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing incidence of target diseases to support growth
TABLE 72 CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 73 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 74 EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 75 EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 76 EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 77 EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Inconsistent reimbursement for compression therapy products to restrain market growth
TABLE 78 GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising prevalence of lymphedema and DVT to drive market
TABLE 79 UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 High incidence of diabetes to drive demand for compression therapy
TABLE 80 FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising awareness about preventive care for musculoskeletal injuries to fuel growth
TABLE 81 ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing presence of key manufacturers to increase access to compression therapy products
TABLE 82 SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 83 HIP AND KNEE SURGERY PROCEDURES (PER 100,000 PEOPLE) IN EUROPEAN COUNTRIES
TABLE 84 REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT
TABLE 85 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 86 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 87 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 88 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan to dominate Asia Pacific compression therapy market
TABLE 90 JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Modernization of healthcare facilities to drive market growth
TABLE 91 CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing number of hip & knee surgeries to support market
TABLE 92 INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Government subsidies related to compression garments for lymphedema patients to promote growth
TABLE 93 AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Increasing number of plastic surgeries to drive demand for compression garments
TABLE 94 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 95 REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 96 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 97 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 98 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 100 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Rising number of cosmetic surgeries to support market
TABLE 101 BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Lack of reimbursement for bracing products to limit growth
TABLE 102 MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 103 REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 UNFAVORABLE REIMBURSEMENT SCENARIO TO HAMPER MARKET GROWTH
TABLE 104 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 106 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPRESSION THERAPY MARKET
TABLE 108 STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES
11.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 31 COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2021
11.5 COMPETITIVE SITUATIONS AND TRENDS
TABLE 109 COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION
11.6 COMPANY EVALUATION QUADRANT
11.7 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021)
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
FIGURE 32 COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
11.8 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2021)
11.8.1 PROGRESSIVE COMPANIES
11.8.2 STARTING BLOCKS
11.8.3 RESPONSIVE COMPANIES
11.8.4 DYNAMIC COMPANIES
FIGURE 33 COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2021)
11.9 COMPETITIVE BENCHMARKING
FIGURE 34 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET
TABLE 110 COMPANY PRODUCT FOOTPRINT
TABLE 111 COMPANY REGIONAL FOOTPRINT
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES
11.10.2 DEALS
11.10.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 3M
TABLE 112 3M: BUSINESS OVERVIEW
FIGURE 35 3M: COMPANY SNAPSHOT (2021)
12.1.2 ARJOHUNTLEIGH
TABLE 113 ARJOHUNTLEIGH: BUSINESS OVERVIEW
FIGURE 36 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2021)
12.1.3 BIO COMPRESSION SYSTEMS, INC.
TABLE 114 BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW
12.1.4 BSN MEDICAL (A SUBSIDIARY OF ESSITY)
TABLE 115 ESSITY: BUSINESS OVERVIEW
FIGURE 37 ESSITY: COMPANY SNAPSHOT (2021)
12.1.5 CARDINAL HEALTH, INC.
TABLE 116 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
12.1.6 CONVATEC INC.
TABLE 117 CONVATEC INC.: BUSINESS OVERVIEW
FIGURE 39 CONVATEC INC.: COMPANY SNAPSHOT (2021)
12.1.7 DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION)
TABLE 118 DJO, LLC: BUSINESS OVERVIEW
FIGURE 40 COLFAX CORPORATION: COMPANY SNAPSHOT (2021)
12.1.8 JULIUS ZORN GMBH
TABLE 119 JULIUS ZORN GMBH: BUSINESS OVERVIEW
12.1.9 MEDI GMBH & CO. KG
TABLE 120 MEDI GMBH & CO. KG: BUSINESS OVERVIEW
12.1.10 PAUL HARTMANN AG
TABLE 121 PAUL HARTMANN AG: BUSINESS OVERVIEW
FIGURE 41 PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)
12.1.11 SANYLEG S.R.L.
TABLE 122 SANYLEG S.R.L.: BUSINESS OVERVIEW
12.1.12 SIGVARIS GROUP
TABLE 123 SIGVARIS GROUP: BUSINESS OVERVIEW
12.1.13 SMITH & NEPHEW PLC
TABLE 124 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 42 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
12.1.14 TACTILE SYSTEMS TECHNOLOGY, INC. (“TACTILE MEDICAL”)
TABLE 125 TACTILE MEDICAL: BUSINESS OVERVIEW
FIGURE 43 TACTILE MEDICAL: COMPANY SNAPSHOT (2021)
12.1.15 MEGO AFEK LTD.
TABLE 126 MEGO AFEK LTD.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 MEDLINE INDUSTRIES, LP
12.2.2 GOTTFRIED MEDICAL, INC.
12.2.3 THERMOTEK, INC.
12.2.4 BAUERFEIND AG
12.2.5 OFA BAMBERG GMBH
12.2.6 ACI MEDICAL, LLC
12.2.7 AIROS MEDICAL INC.
12.2.8 BARCELCOM T?XTEIS, S.A.
12.2.9 CIZETA MEDICALI S.P.A.
12.2.10 B?SL MEDIZINTECHNIK
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 KEY MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Indicative list of secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 RECESSION IMPACT
2.3.1 IMPACT OF RECESSION ON COMPRESSION THERAPY MARKET
2.4 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 7 COMPRESSION THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 8 COMPRESSION THERAPY MARKET SHARE, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 COMPRESSION THERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 10 COMPRESSION THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF COMPRESSION THERAPY MARKET
4 PREMIUM INSIGHTS
4.1 COMPRESSION THERAPY MARKET OVERVIEW
FIGURE 12 GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH
4.2 COMPRESSION THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 13 COMPRESSION PUMPS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 STATIC COMPRESSION THERAPY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)
FIGURE 15 HOSPITALS & CLINICS TO ACCOUNT FOR LARGEST SHARE OF COMPRESSION THERAPY MARKET IN 2027
4.5 COMPRESSION THERAPY MARKET, BY REGION, 2020–2027
FIGURE 16 ASIA PACIFIC TO WITNESS FASTEST GROWTH IN MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Large target patient population
FIGURE 18 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050
5.2.1.2 Growing incidence of sports injuries and accidents
FIGURE 19 EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 2021
5.2.1.3 Increasing number of orthopedic procedures
5.2.1.4 Greater product affordability and market availability
5.2.1.5 Clinical evidence favoring adoption of compression therapy for management of target conditions
5.2.2 RESTRAINTS
5.2.2.1 Lack of universally accepted standards for compression products
5.2.2.2 Low patient compliance with compression garments
FIGURE 20 REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential offered by emerging markets
5.2.3.2 Growing patient awareness regarding benefits of compression therapy
5.2.3.3 Increased sales of off-the-shelf and online products
5.2.4 CHALLENGES
5.2.4.1 Significant adoption of alternative therapies for specific target indications
5.2.4.2 Increasing pricing pressure on market players
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 OVERVIEW
TABLE 2 COMPRESSION THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.2 BARGAINING POWER OF BUYERS
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 THREAT FROM NEW ENTRANTS
5.3.5 THREAT FROM SUBSTITUTES
5.3.6 INTENSITY OF COMPETITIVE RIVALRY
5.4 PRICING TREND ANALYSIS
5.4.1 AVERAGE SELLING PRICE, BY PRODUCT
TABLE 3 AVERAGE PRICE OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)
5.4.2 AVERAGE SELLING PRICE, BY REGION
TABLE 4 REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)
5.5 TECHNOLOGY ANALYSIS
5.5.1 WIRELESS BIOSENSORS
5.5.2 GARMENT MANUFACTURING TECHNOLOGIES
5.6 REGULATORY ANALYSIS
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.6.1.2 Canada
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2 EUROPE
FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6.3.2 China
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
5.7 REIMBURSEMENT SCENARIO
TABLE 10 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2021
5.8 VALUE CHAIN ANALYSIS
FIGURE 23 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.9.3 END USERS
FIGURE 24 SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM ANALYSIS
5.10.1 PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS
5.11 PATENT ANALYSIS
FIGURE 25 PATENT ANALYSIS
5.12 TRADE ANALYSIS
TABLE 11 IMPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)
TABLE 12 EXPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)
5.13 KEY CONFERENCES & EVENTS, 2022–2023
5.13.1 COMPRESSION THERAPY MARKET: LIST OF MAJOR CONFERENCES & EVENTS
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY DISTRIBUTION CHANNEL
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL (%)
5.14.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL
TABLE 14 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL
6 COMPRESSION THERAPY MARKET, BY TECHNIQUE
6.1 INTRODUCTION
TABLE 15 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
6.2 STATIC COMPRESSION THERAPY
6.2.1 PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH
TABLE 16 STATIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 DYNAMIC COMPRESSION THERAPY
6.3.1 RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET
TABLE 17 DYNAMIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
7 COMPRESSION THERAPY MARKET, BY PRODUCT
7.1 INTRODUCTION
TABLE 18 COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
7.2 COMPRESSION BANDAGES
7.2.1 LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH
TABLE 19 COMPRESSION BANDAGES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 20 COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 21 COMPRESSION BANDAGES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 22 COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.3 COMPRESSION WRAPS
7.3.1 RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET
TABLE 23 COMPRESSION WRAPS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 24 COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 25 COMPRESSION WRAPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 26 COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.4 COMPRESSION STOCKINGS
TABLE 27 COMPRESSION STOCKINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 28 COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 29 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 30 COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 31 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.4.1 CLASS I COMPRESSION STOCKINGS
7.4.1.1 Advantages such as comfort and durability to drive demand for class I stockings
TABLE 32 CLASS I COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.4.2 CLASS II COMPRESSION STOCKINGS
7.4.2.1 Increasing number of lymphedema and DVT patients to fuel demand
TABLE 33 CLASS II COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.4.3 CLASS III COMPRESSION STOCKINGS
7.4.3.1 High level of compression provided to boost adoption of class III stockings
TABLE 34 CLASS III COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.5 COMPRESSION TAPES
7.5.1 ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES
TABLE 35 COMPRESSION TAPES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 36 COMPRESSION TAPES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 37 COMPRESSION TAPES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 38 COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.6 COMPRESSION PUMPS
TABLE 39 COMPRESSION PUMPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 41 COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 42 COMPRESSION PUMPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 43 COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.6.1 INTERMITTENT PUMPS
7.6.1.1 Availability of wide range of intermittent pumps with varying designs and complexity to boost demand
TABLE 44 INTERMITTENT COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.6.2 SEQUENTIAL PUMPS
7.6.2.1 Wide usage to prevent development of DVT to boost growth
TABLE 45 SEQUENTIAL COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.7 COMPRESSION BRACES
7.7.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET
TABLE 46 COMPRESSION BRACES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 47 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 48 COMPRESSION BRACES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 49 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
7.8 OTHER COMPRESSION GARMENTS
TABLE 50 OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 51 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 52 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
8 COMPRESSION THERAPY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 54 COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027(USD MILLION)
8.2 VARICOSE VEIN TREATMENT
8.2.1 GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET
TABLE 55 COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2020–2027 (USD MILLION)
8.3 DEEP VEIN THROMBOSIS TREATMENT
8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH
TABLE 56 COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2020–2027 (USD MILLION)
8.4 LYMPHEDEMA TREATMENT
8.4.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH
TABLE 57 COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2020–2027 (USD MILLION)
8.5 LEG ULCER TREATMENT
8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET
TABLE 58 COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2020–2027 (USD MILLION)
8.6 OTHER APPLICATIONS
TABLE 59 COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL
9.1 INTRODUCTION
TABLE 60 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
9.2 PHARMACIES & RETAILERS
9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH
TABLE 61 COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2020–2027 (USD MILLION)
9.3 E-COMMERCE PLATFORMS
9.3.1 E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD
TABLE 62 COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2020–2027 (USD MILLION)
9.4 HOSPITALS & CLINICS
9.4.1 HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH
TABLE 63 COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)
9.5 HOME CARE SETTINGS
9.5.1 GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET
TABLE 64 COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
10 COMPRESSION THERAPY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 65 COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT
TABLE 66 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 Rising number of sports injuries to drive market growth
TABLE 71 US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing incidence of target diseases to support growth
TABLE 72 CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 73 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 74 EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 75 EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 76 EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 77 EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Inconsistent reimbursement for compression therapy products to restrain market growth
TABLE 78 GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising prevalence of lymphedema and DVT to drive market
TABLE 79 UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 High incidence of diabetes to drive demand for compression therapy
TABLE 80 FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising awareness about preventive care for musculoskeletal injuries to fuel growth
TABLE 81 ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing presence of key manufacturers to increase access to compression therapy products
TABLE 82 SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 83 HIP AND KNEE SURGERY PROCEDURES (PER 100,000 PEOPLE) IN EUROPEAN COUNTRIES
TABLE 84 REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT
TABLE 85 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 86 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 87 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 88 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan to dominate Asia Pacific compression therapy market
TABLE 90 JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Modernization of healthcare facilities to drive market growth
TABLE 91 CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing number of hip & knee surgeries to support market
TABLE 92 INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Government subsidies related to compression garments for lymphedema patients to promote growth
TABLE 93 AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Increasing number of plastic surgeries to drive demand for compression garments
TABLE 94 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 95 REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 96 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 97 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 98 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 100 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Rising number of cosmetic surgeries to support market
TABLE 101 BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Lack of reimbursement for bracing products to limit growth
TABLE 102 MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 103 REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 UNFAVORABLE REIMBURSEMENT SCENARIO TO HAMPER MARKET GROWTH
TABLE 104 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 106 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPRESSION THERAPY MARKET
TABLE 108 STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES
11.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 31 COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2021
11.5 COMPETITIVE SITUATIONS AND TRENDS
TABLE 109 COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION
11.6 COMPANY EVALUATION QUADRANT
11.7 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021)
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
FIGURE 32 COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
11.8 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2021)
11.8.1 PROGRESSIVE COMPANIES
11.8.2 STARTING BLOCKS
11.8.3 RESPONSIVE COMPANIES
11.8.4 DYNAMIC COMPANIES
FIGURE 33 COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2021)
11.9 COMPETITIVE BENCHMARKING
FIGURE 34 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET
TABLE 110 COMPANY PRODUCT FOOTPRINT
TABLE 111 COMPANY REGIONAL FOOTPRINT
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES
11.10.2 DEALS
11.10.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 3M
TABLE 112 3M: BUSINESS OVERVIEW
FIGURE 35 3M: COMPANY SNAPSHOT (2021)
12.1.2 ARJOHUNTLEIGH
TABLE 113 ARJOHUNTLEIGH: BUSINESS OVERVIEW
FIGURE 36 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2021)
12.1.3 BIO COMPRESSION SYSTEMS, INC.
TABLE 114 BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW
12.1.4 BSN MEDICAL (A SUBSIDIARY OF ESSITY)
TABLE 115 ESSITY: BUSINESS OVERVIEW
FIGURE 37 ESSITY: COMPANY SNAPSHOT (2021)
12.1.5 CARDINAL HEALTH, INC.
TABLE 116 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
12.1.6 CONVATEC INC.
TABLE 117 CONVATEC INC.: BUSINESS OVERVIEW
FIGURE 39 CONVATEC INC.: COMPANY SNAPSHOT (2021)
12.1.7 DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION)
TABLE 118 DJO, LLC: BUSINESS OVERVIEW
FIGURE 40 COLFAX CORPORATION: COMPANY SNAPSHOT (2021)
12.1.8 JULIUS ZORN GMBH
TABLE 119 JULIUS ZORN GMBH: BUSINESS OVERVIEW
12.1.9 MEDI GMBH & CO. KG
TABLE 120 MEDI GMBH & CO. KG: BUSINESS OVERVIEW
12.1.10 PAUL HARTMANN AG
TABLE 121 PAUL HARTMANN AG: BUSINESS OVERVIEW
FIGURE 41 PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)
12.1.11 SANYLEG S.R.L.
TABLE 122 SANYLEG S.R.L.: BUSINESS OVERVIEW
12.1.12 SIGVARIS GROUP
TABLE 123 SIGVARIS GROUP: BUSINESS OVERVIEW
12.1.13 SMITH & NEPHEW PLC
TABLE 124 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 42 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
12.1.14 TACTILE SYSTEMS TECHNOLOGY, INC. (“TACTILE MEDICAL”)
TABLE 125 TACTILE MEDICAL: BUSINESS OVERVIEW
FIGURE 43 TACTILE MEDICAL: COMPANY SNAPSHOT (2021)
12.1.15 MEGO AFEK LTD.
TABLE 126 MEGO AFEK LTD.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 MEDLINE INDUSTRIES, LP
12.2.2 GOTTFRIED MEDICAL, INC.
12.2.3 THERMOTEK, INC.
12.2.4 BAUERFEIND AG
12.2.5 OFA BAMBERG GMBH
12.2.6 ACI MEDICAL, LLC
12.2.7 AIROS MEDICAL INC.
12.2.8 BARCELCOM T?XTEIS, S.A.
12.2.9 CIZETA MEDICALI S.P.A.
12.2.10 B?SL MEDIZINTECHNIK
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
